Table 4 Association of rs895819T/C genotypes with clinical parameters in preeclampsia and HIV co-infection
(a) Preeclampsia (n = 56) | ||||
Variable | TT vs. TC/CC | p-value | ||
BMI (kg/m2) | 29.25 ± 1.084 vs. 32.57 ± 1.344 | 0.0643 | ||
EOPE (%) | 31 vs. 42 | 0.5346 | ||
Severe PE (%) | 38 vs. 49 | 0.5453 | ||
SYS BP (mmHg) | 154.5 ± 3.890 vs. 160.8 ± 2.342 | 0.1810 | ||
DIA BP (mmHg) | 100.0 ± 2.614 vs. 105.0 ± 1.692 | 0.1268 | ||
(b) | PE HIV- (n = 29) | PE HIV+ ( n = 27) | ||
Variable | TT vs. TC/CC | p-value | TT vs. TC/CC | p-value |
BMI (kg/m2) | 29.5 ± 1.45 vs. 31.7 ± 2.11 | 0.3882 | 27.8 ± 0.69 vs. 33.47 ± 1.66 | 0.0059* |
EOPE (%) | 25 vs. 29 | 1.000 | 40 vs. 55 | 0.6483 |
Severe PE (%) | 38 vs. 38 | 1.000 | 40 vs. 59 | 0.6280 |
SYS BP (mmHg) | 153 ± 5.91 vs. 161.7 ± 5.1 | 0.2946 | 156 ± 4.986 vs. 163 ± 3.224 | 0.2764 |
DIABP (mmHg) | 99 ± 3.51 vs. 102 ± 2.38 | 0.5116 | 102 ± 4.250 vs. 108 ± 2.274 | 0.2507 |